Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-04 18:00 |
Déclaration d’actions et de droits de vote - Valneva SE - 30 juin 2024
|
French | 157.5 KB | ||
| 2024-07-04 18:00 |
Declaration of shares and voting rights - Valneva SE - June 30, 2024
|
English | 52.7 KB | ||
| 2024-07-01 07:00 |
Valneva Receives Marketing Authorization in Europe for the World’s First Chikun…
|
English | 204.5 KB | ||
| 2024-07-01 07:00 |
Valneva reçoit une autorisation de mise sur le marché en Europe pour le premier…
|
French | 178.6 KB | ||
| 2024-06-26 17:45 |
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 146.2 KB | ||
| 2024-06-26 17:45 |
Valneva Announces Successful Outcome of its Combined General Meeting and Appoin…
|
English | 110.0 KB | ||
| 2024-06-24 07:00 |
Valneva annonce l’approbation par Santé Canada du premier vaccin au monde contr…
|
French | 209.0 KB | ||
| 2024-06-24 07:00 |
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vacci…
|
English | 161.7 KB | ||
| 2024-06-05 07:00 |
Valneva annonce la mise à disposition des documents préparatoires à son Assembl…
|
French | 115.5 KB | ||
| 2024-06-05 07:00 |
Valneva Announces Availability of Documentation for its Combined Shareholder Me…
|
English | 110.8 KB | ||
| 2024-06-04 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2024
|
French | 13.7 KB | ||
| 2024-06-04 18:00 |
VALNEVA - Declaration of shares and voting rights: May 31, 2024
|
English | 13.9 KB | ||
| 2024-06-04 17:35 |
Valneva annonce sa participation à différentes conférences investisseurs du moi…
|
French | 112.0 KB | ||
| 2024-06-04 17:35 |
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
|
English | 109.9 KB | ||
| 2024-06-03 17:35 |
Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme…
|
French | 204.7 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
